Cargando…
Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation
ADP-ribosylation (ADPr) is a post-translational modification that plays pivotal roles in a wide range of cellular processes. Mass spectrometry (MS)-based analysis of ADPr under physiological conditions, without relying on genetic or chemical perturbation, has been hindered by technical limitations....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s).
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508052/ https://www.ncbi.nlm.nih.gov/pubmed/32966781 http://dx.doi.org/10.1016/j.celrep.2020.108176 |
_version_ | 1783585351541981184 |
---|---|
author | Buch-Larsen, Sara C. Hendriks, Ivo A. Lodge, Jean M. Rykær, Martin Furtwängler, Benjamin Shishkova, Evgenia Westphall, Michael S. Coon, Joshua J. Nielsen, Michael L. |
author_facet | Buch-Larsen, Sara C. Hendriks, Ivo A. Lodge, Jean M. Rykær, Martin Furtwängler, Benjamin Shishkova, Evgenia Westphall, Michael S. Coon, Joshua J. Nielsen, Michael L. |
author_sort | Buch-Larsen, Sara C. |
collection | PubMed |
description | ADP-ribosylation (ADPr) is a post-translational modification that plays pivotal roles in a wide range of cellular processes. Mass spectrometry (MS)-based analysis of ADPr under physiological conditions, without relying on genetic or chemical perturbation, has been hindered by technical limitations. Here, we describe the applicability of activated ion electron transfer dissociation (AI-ETD) for MS-based proteomics analysis of physiological ADPr using our unbiased Af1521 enrichment strategy. To benchmark AI-ETD, we profile 9,000 ADPr peptides mapping to >5,000 unique ADPr sites from a limited number of cells exposed to oxidative stress and identify 120% and 28% more ADPr peptides compared to contemporary strategies using ETD and electron-transfer higher-energy collisional dissociation (EThcD), respectively. Under physiological conditions, AI-ETD identifies 450 ADPr sites on low-abundant proteins, including in vivo cysteine modifications on poly(ADP-ribosyl)polymerase (PARP) 8 and tyrosine modifications on PARP14, hinting at specialist enzymatic functions for these enzymes. Collectively, our data provide insights into the physiological regulation of ADPr. |
format | Online Article Text |
id | pubmed-7508052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Author(s). |
record_format | MEDLINE/PubMed |
spelling | pubmed-75080522020-09-23 Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation Buch-Larsen, Sara C. Hendriks, Ivo A. Lodge, Jean M. Rykær, Martin Furtwängler, Benjamin Shishkova, Evgenia Westphall, Michael S. Coon, Joshua J. Nielsen, Michael L. Cell Rep Resource ADP-ribosylation (ADPr) is a post-translational modification that plays pivotal roles in a wide range of cellular processes. Mass spectrometry (MS)-based analysis of ADPr under physiological conditions, without relying on genetic or chemical perturbation, has been hindered by technical limitations. Here, we describe the applicability of activated ion electron transfer dissociation (AI-ETD) for MS-based proteomics analysis of physiological ADPr using our unbiased Af1521 enrichment strategy. To benchmark AI-ETD, we profile 9,000 ADPr peptides mapping to >5,000 unique ADPr sites from a limited number of cells exposed to oxidative stress and identify 120% and 28% more ADPr peptides compared to contemporary strategies using ETD and electron-transfer higher-energy collisional dissociation (EThcD), respectively. Under physiological conditions, AI-ETD identifies 450 ADPr sites on low-abundant proteins, including in vivo cysteine modifications on poly(ADP-ribosyl)polymerase (PARP) 8 and tyrosine modifications on PARP14, hinting at specialist enzymatic functions for these enzymes. Collectively, our data provide insights into the physiological regulation of ADPr. The Author(s). 2020-09-22 2020-09-22 /pmc/articles/PMC7508052/ /pubmed/32966781 http://dx.doi.org/10.1016/j.celrep.2020.108176 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Resource Buch-Larsen, Sara C. Hendriks, Ivo A. Lodge, Jean M. Rykær, Martin Furtwängler, Benjamin Shishkova, Evgenia Westphall, Michael S. Coon, Joshua J. Nielsen, Michael L. Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation |
title | Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation |
title_full | Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation |
title_fullStr | Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation |
title_full_unstemmed | Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation |
title_short | Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation |
title_sort | mapping physiological adp-ribosylation using activated ion electron transfer dissociation |
topic | Resource |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508052/ https://www.ncbi.nlm.nih.gov/pubmed/32966781 http://dx.doi.org/10.1016/j.celrep.2020.108176 |
work_keys_str_mv | AT buchlarsensarac mappingphysiologicaladpribosylationusingactivatedionelectrontransferdissociation AT hendriksivoa mappingphysiologicaladpribosylationusingactivatedionelectrontransferdissociation AT lodgejeanm mappingphysiologicaladpribosylationusingactivatedionelectrontransferdissociation AT rykærmartin mappingphysiologicaladpribosylationusingactivatedionelectrontransferdissociation AT furtwanglerbenjamin mappingphysiologicaladpribosylationusingactivatedionelectrontransferdissociation AT shishkovaevgenia mappingphysiologicaladpribosylationusingactivatedionelectrontransferdissociation AT westphallmichaels mappingphysiologicaladpribosylationusingactivatedionelectrontransferdissociation AT coonjoshuaj mappingphysiologicaladpribosylationusingactivatedionelectrontransferdissociation AT nielsenmichaell mappingphysiologicaladpribosylationusingactivatedionelectrontransferdissociation |